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1. Introduction
The advance of different analytical methods in mass spectrometry within the last twenty
years has opened the door to breath gas analysis. There is considerable evidence that
volatile organic compounds (VOCs) produced in the human body and then partially
released in breath have great potential for diagnosis in physiology and medicine [3].
The emission of such compounds may result from normal human metabolism as well
as from pathophysiological disorders, bacterial or mycotic processes (see [1] and the
references therein), or exposure to environmental contaminants [20, 21, 27]. As subject-
specific chemical fingerprints, VOCs can provide non-invasive and real-time information
on infections, metabolic disorders, and the progression of therapeutic intervention.
In a recent paper Spanel et al. [26] investigated the short-term effect of inhaled
VOCs on their exhaled breath concentrations. They showed for seven different VOCs
that the exhaled breath concentration closely resembles an affine function of the
inhaled concentration. This motivated our theoretical investigation regarding the
impact of inhaled concentrations for VOCs with low blood:air partition coefficients,
i.e., compounds with exhalation kinetics that are described by the Farhi equation [5].
To this extent we develop a simple two compartment model which generalizes the
Farhi equation to the case in which the inhaled concentration of a VOC is not negligible.
In accordance with the above-mentioned experimental observations, the model predicts
that when ventilation and perfusion are kept constant the exhaled breath concentration
is indeed an affine function of the inhaled concentration. In addition it links the exhaled
breath concentration of systemic VOCs to physiological parameters such as endogenous
production rates and metabolic rates, thereby complementing similar efforts in the
framework of exposure studies [22, 4]. This estimation process is exemplified by means
of exhalation data for endogenous isoprene and inhaled deuterated isoprene-D5.
Another interesting aspect of the model is that for low-soluble VOCs it illustrates a
novel approach for answering the question “Is subtracting the inhaled concentration from
the exhaled concentration a suitable method to correct measured breath concentrations
for room air concentrations?”, an issue that is still being debated within the breath
analysis community [19, 23]. In the discussions we indicate how to extend these results
to VOCs with higher partition coefficients and how to take into account long-term
exposure.
A list of symbols used is provided in Appendix A.
2. A two compartment model
2.1. Derivation of the Farhi equation
To derive the classical Farhi equation which relates alveolar concentrations of VOCs
to their underlying blood concentrations one uses a simple two compartment model
(see Figure 1) which consists of one single lung compartment and one single body
compartment.
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Figure 1. Two compartment model consisting of a lung compartment (gas exchange)
and a body compartment with production and metabolism. Dashed lines indicate
equilibrium according to Henry’s law.
The amount of a VOC transported at time t to and from the lung via blood flow
is given by
Q˙c(t)(Cv¯(t)− Ca(t)),
where Q˙c denotes the cardiac output, Cv¯ is the averaged mixed venous concentration,
and Ca is the arterial concentration.
On the other hand, the amount exhaled equals
V˙A(t)(CI − CA(t)),
where V˙A denotes the ventilation, CI denotes the concentration in the inhaled air
(normally assumed to be zero), and CA the alveolar air concentration.
This leads to the following mass balance equation describing the change in the
concentration of a VOC in the lung‡ (see Figure 2)
V˜A
dCA
dt
= V˙A(CI − CA) + Q˙c(Cv¯ − Ca), (1)
where V˜A denotes the volume of the lung.
air
blood
CI
Cv¯
CA
Ca
-V˙A
-Q˙c
Figure 2. Diagram of gas exchange in an alveoli symbolized by a dashed line.
If the system is in an equilibrium state (e.g., stationary at rest) Equation (1) reads
0 = V˙A(CI−CA(CI)) + Q˙c(Cv¯(CI)−Ca) and using Henry’s law Ca = λb:airCA we obtain
CA(CI) =
CI
λb:air
r
+ 1
+
Cv¯(CI)
λb:air + r
, (2)
‡ For notational convenience we have dropped the time variable t, i.e., we write CX instead of CX(t),
etc. CX denotes the instant or averaged concentration of X over a small sampling period τ , i.e.,
CX(t) = 1/τ
∫ t+τ/2
t−τ/2 CX(s)ds.
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where r = V˙A/Q˙c is the ventilation-perfusion ratio and λb:air denotes the blood:air
partition coefficient. The fact is stressed here that CA and Cv¯ depend on the inhaled
concentration CI. In particular, this means that if CI 6= 0, then subtracting CI from
CA to arrive at an estimate for CA(0) will generally give misleading results (more in
Subsection 2.3).
Assuming that CI = 0 we derive the classical Farhi equation [5]
CA(0) =
Cv¯(0)
λb:air + r
. (3)
We summarize the assumptions for the validity of Farhi’s equation and the
following extensions:
(i) the inhaled concentration is zero, i.e., CI = 0
(ii) a stationary state is achieved within the lung, i.e., dCA
dt
= 0
(iii) the lung behaves uniformly with respect to ventilation and perfusion (a
condition that is typically violated in most lung diseases)
(iv) absorption/desorption phenomena within the upper airways are negligible (i.e.,
low solubility of the VOC in the airway mucus layer, which is generally fulfilled
if λb:air < 10, see [2])
(v) only alveolar air is sampled so that the alveolar concentration is equal to the
exhaled concentration, CA = Cexhaled; in particular, this implies that dead space
air contributions have to be avoided, e.g., by CO2 controlled sampling, and that
no airway production (as in the case of NO) takes place
(vi) no reactions with other breath constituents occur, i.e., the VOC under scrutiny
is largely inert
(vii) the distribution of the blood flow into the different body compartments remains
unchanged (e.g., constant at rest)
Note that despite its simplicity, the Farhi equation yields first valuable insights into
the exhalation kinetics of VOCs. For instance, the breath concentration of compounds
with a low blood:gas partition coefficient λb:air is expected to react very sensitively to
changes of the ventilation-perfusion ratio r (e.g., during exercise, hyperventilation, or
breath holding [24]). Typical examples include methane or butane [25, 10].
2.2. Extension of the Farhi equation
To calculate the explicit dependence of CA and Cv¯ on CI we need to consider the mass
balance for the body compartment too. The change of the amount of a VOC in the body
is given by the amount which enters the body compartment with the arterial blood plus
the amount which is produced in the body minus the amount which is metabolized and
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the amount leaving via venous blood. Thus the change of the amount of a VOC in the
body compartment is given by§,‖
V˜B
dCB
dt
= Q˙c(Ca − Cv¯)− λb:BkmetCB + kprod, (4)
where kmet denotes the metabolic rate, kprod the production rate, V˜B the effective volume
of the body¶, and CB the concentration in the body which is connected to the venous
concentration by Henry’s law Cv¯ = λb:B CB. Here λb:B denotes the blood:body tissue
partition coefficient.
When in an equilibrium state (i.e., dCA
dt
= 0 and dCB
dt
= 0) we can use Equations (1),
(4), and Cv¯ = λb:B CB to eliminate the implicit dependence of CA on CI in Equation (2)
CA(CI) =
kprod
kmet
r + V˙A
kmet
+ λb:air
+
r + V˙A
kmet
r + V˙A
kmet
+ λb:air
CI , (5)
Cv¯(CI) =
kprod
kmet
(r + λb:air)
r + V˙A
kmet
+ λb:air
+
λb:air
kmet
r
r + V˙A
kmet
+ λb:air
CI . (6)
From Equation (5) and (6) we see that the exhaled concentration CA and the mixed
venous concentration Cv¯ solely depend on the inhaled concentration CI and the
physiological parameters kprod, kmet, V˙A, Q˙c, λb:air.
We now discuss some special cases:
(a) For CI = 0 (no trace gas is inspired) this reduces to
CA(0) =
kprod
kmet
r + V˙A
kmet
+ λb:air
,
Cv¯(0) =
kprod
kmet
(r + λb:air)
r + V˙A
kmet
+ λb:air
= CA(0) (r + λb:air). (7)
(b) On the other hand, when the production is zero (kprod = 0), this yields
CA(CI) =
r + V˙A
kmet
r + V˙A
kmet
+ λb:air
CI =
1
1 + λb:air
r+
V˙A
kmet
CI , CA(CI) ≤ CI , (8)
Cv¯(CI) =
λb:air
kmet
r
r + V˙A
kmet
+ λb:air
CI =
λb:air
kmet + Q˙c
CA(CI). (9)
§ Here we used the usual convention to multiply kmet by λb:B . It would be more natural to use kmet
only but this can be incorporated in a redefinition of kmet.
‖ Since the considered inhaled concentrations are low, linear elimination kinetics are sufficient for the
description.
¶ The body blood compartment and the body tissue compartment are assumed to be in an equilibrium
and therefore can be combined into one single body compartment with an effective volume. For more
details about effective volume compare appendix 2 in [12].
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(c) Assuming CA = CI (zero alveolar gradient) in Equation (5) yields
CI =
kprod
kmet λb:air
. (10)
2.3. Is subtracing CI a suitable correction method in order to account for inhaled VOC
concentrations?
The contribution of room air concentrations to breath concentrations is a long lasting
problem in breath gas analysis (see, e.g., [19], [23], [6] and the reviews [16], [18]). In
[19], M. Phillips summarized the situation as follows:
Researchers have responded to the problem of room air concentrations with three
different strategies:
(1) Ignore the problem.
(2) Provide the subject with VOC-free air to breathe prior to collection of the breath
sample. Unfortunately high quality pure breathing air from commercial sources is
usually found to contain a large number of VOCs. In addition it will also contribute
to the wash-in/wash-out effect.
(3) Correct for the problem by subtracting the background VOCs in room air from the
VOCs observed in the breath.
He calls this difference of exhaled concentration and inhaled concentration the
alveolar gradient, i.e., it is assumed that CA(0) = CA(CI)−CI. To see if this subtraction
is correct we consider Equation (5), which we rewrite as
CA(CI) = CA(0) +
1
1 + λb:air
r+
V˙A
kmet
CI .
Hence
CA(0) = CA(CI)− 1
1 + λb:air
r+
V˙A
kmet
CI . (11)
From this result we conclude that simply subtracting or ignoring the inhaled
concentration is generally false. More precisely, for VOCs which fulfill the assumptions
made above, CI needs to be multiplied by the following factor
a :=
1
1 + λb:air
r+
V˙A
kmet
(12)
before subtraction. This factor a is approximately 1 for small values of λb:air (e.g.,
methane, for which λb:air < 0.1) or for small values of kmet (no metabolism). But it
might be 2/3 if, e.g., λb:air
r+
V˙A
kmet
= 1/2.
For perspective, Spanel et al. experimentally determined a = 0.67 for isoprene and
a = 0.81 for pentane [26]. Thus one should use the correction CA(0) = CA(CI)−0.67CI
for isoprene and CA(0) = CA(CI)− 0.81CI for pentane.
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2.4. Endogenous production and metabolic rates
The question remains how to determine the endogenous production rate and the total
metabolic rate of the body using the theoretical framework introduced above. When in
a stationary state the averaged values of ventilation and perfusion are constant. Thus
Equation (5) resembles a straight line of the form
CA(CI) = aCI + b, (13)
CI being the variable here. The constants a and b are given by
b = CA(0) =
kprod
kmet
r + V˙A
kmet
+ λb:air
(14)
and
a =
(r + V˙A
kmet
)
r + V˙A
kmet
+ λb:air
. (15)
Thus the constants a and b are completely determined by the physiological quantities
V˙A, Q˙c, kprod, kmet, and λb:air. The gradient a is independent of kprod, fulfills 0 < a < 1,
and is determined by the metabolic rate kmet, the ventilation, and perfusion. The
quantity b = CA(0) is proportional to the production rate kprod.
Varying CI , one can measure CA(CI) experimentally and thus determine a and
b. Measuring in addition ventilation and perfusion allows for calculating the total
production rate and the total metabolic rate of the body from these two equations
kprod =
b
1−a λb:air V˙A
a
1−a λb:air − r
, (16)
kmet =
V˙A
a
1−a λb:air − r
, (17)
or
kprod = (V˙A + (r + λb:air) kmet)CA(0), (18)
if kmet is known.
Remark 1: In [26], Spanel et al. studied the effect of inhaled VOCs on exhaled breath
concentrations. Unfortunately, breath frequency and heart rate were not reported.
Therefore ventilation and perfusion are unknown and thus kprod and kmet cannot be
estimated. However, this study shows that Equation (5) explains the experimental
findings very well.
Remark 2: This approach yields total endogenous production rates only. As
such, one will not be able to determine different production rates in different body
compartments. If more than one production source exists, a multi compartment model
needs to be set up for the body. Then changes of r, e.g., by exercise will vary the
fractional blood flows into these compartments, which subsequently allows for estimating
compartment-specific production rates.
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Remark 3: Due to the term (−r) in the denominator of Equation (17), errors when
measuring a, V˙A, and Q˙c may cause considerable errors in the rate estimation.
2.5. Changes in production rates
When measuring breath samples or performing ergometer experiments one assumes
that the endogenous production rate stays constant during the time frame of these
experiments. However, when performing breath analysis during sleep it is possible that
the production rate will display, e.g., a circadian rhythm which can be determined by
(ventilation and perfusion are considered to be constant)
kprod(t) = (V˙A + (r + λb:air) kmet)CA,0(t). (19)
3. Experimental findings
In order to validate the present model, end-tidal concentration profiles of endogenous
isoprene and inhaled deuterated isoprene-D5 were obtained by means of a real-time setup
designed for synchronized measurements of exhaled breath VOCs as well as a number
of respiratory and hemodynamic parameters. Our instrumentation has successfully
been applied for gathering continuous data streams of these quantities during ergometer
challenges [9] as well as in a sleep laboratory setting [8]. These investigations aimed
at evaluating the impact of breathing patterns, cardiac output or blood pressure on
the observed breath concentration and at studying characteristic changes in VOCs
output following variations in ventilation or perfusion. We refer to [9] for an extensive
description of the technical details.
In brief, the core of the mentioned setup consists of a head mask spirometer
system allowing for the standardized extraction of arbitrary exhalation segments,
which subsequently are directed into a Proton-Transfer-Reaction-Time-of-Flight mass
spectrometer (PTR-MS-TOF, Ionicon Analytik GmbH, Innsbruck, Austria) for online
analysis. (The PTR-MS-TOF replaces the formerly used PTR-MS.) This analytical
technique has proven to be a sensitive method for the quantification of volatile molecular
species M down to the ppb (parts per billion) range by taking advantage of the proton
transfer
H3O
+ +M →MH+ + H2O
from primary hydronium precursor ions [14, 15]. Note that this “soft” chemical
ionization scheme is selective to VOCs with proton affinities higher than water
(166.5 kcal/mol). Count rates of the resulting product ions MH+ or fragments thereof
appearing at specified mass-to-charge ratios m/z can subsequently be converted to
absolute concentrations of the compound under scrutiny. Specifically, protonated
isoprene is detected in PTR-MS-TOF at m/z = 69, protonated deuterated isoprene-D5
is detected in PTR-MS-TOF at m/z = 74 and can be measured with breath-by-breath
resolution. An underlying sampling interval of 4 s is set for each parameter.
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For the experiments, deuterated isoprene-D5 (98%, Campro Scientific GmbH,
Germany) was released into the laboratory room with the help of a 0.5-l glass
bulb (Supelco, Canada). In a first step, the bulb was evacuated using a vacuum
membrane pump and an appropriate volume of liquid isoprene (dependent on the target
concentration) was injected through a rubber septum. After complete evaporation of
the compound both Teflon valves of the bulb were opened and the bulb content was
purged with synthetic air at the flow rate of 1 l/min for 3 minutes. Such conditions
provided 3 l of the purge gas (six bulb volumes) to be introduced into the bulb and,
thereby, completely displaced the original bulb content. During the bulb purging the
laboratory air was continuously mixed with the help of a fan to achieve a homogenous
isoprene distribution.
In contrast to chamber experiments the laboratory serves here as a big reservoir
(volume: approx. 60 000 l) with a nearly constant background concentration+. Three of
the authors (one female, two males) took part in five ergometer sessions each (sessions
1–15), at different room air concentrations of deuterated isoprene-D5 (ranging from 30
to 1000 ppb). The exact protocol was as follows (see Figure 3):
• minutes 0–9: the volunteer rests on the ergometer with head-mask on
• minutes 9–12: deuterated isoprene-D5 is released and the room air is mixed by a
fan
• minutes 12–22: volunteer rests on the ergometer
• minutes 22–40: volunteer pedals at 75 Watts
• minutes 40–46: volunteer rests on the ergometer
• minutes 46–58: volunteer pedals at 75 Watts
• minutes 58–63: volunteer rests on the ergometer
• minutes 63–68: mask is taken off and the room air concentration is measured.
4. Results
As one can deduce from the prototypical plot in Figure 3, deuterated isoprene-D5 with
a partition coefficient of nearly 1 (λb:air = 0.95, [17]) enters the arterial blood stream
quickly and it takes only a few minutes until it appears in breath and an equilibrium is
achieved in the room air and the blood of the volunteer. To ensure that a steady state
was achieved we waited another ten minutes before starting with exercise. At the onset
of exercise normal (endogenous) isoprene shows a peak as is well known [9]. This peak
presumably stems from a high concentration in muscle blood caused by the production
in this compartment [7, 11]. Deuterated isoprene-D5 is nowhere produced in the body.
Hence in every compartment of the body its concentration is similar (and zero at the
+ For time frames of a few minutes the room air concentration can considered to be constant; however,
over one hour a decrease in the room air concentration is noticeable due to leaks in the sealing of the
laboratory.
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Figure 3. Typical results of a single ergometer session with inhalation of deuterated
isoprene-D5: rest for 9 min – release of deuterated isoprene-D5 into the sealed
laboratory and waiting for 13 min – 75 Watts for 18 min – rest for 6 min – 75 Watts for
12 min – rest for 5 min; deuterated isoprene-D5 breath concentration: green, normal
isoprene breath concentration: blue. In order to validate the 2-compartment model we
took the average values at rest from minute 19 to 22 (vertical lines). These values are
given in Tables 1 – 3 in column three and four.
beginning of the experiment). At the onset of exercise, the ventilation-perfusion ratio
goes up and the deuterated isoprene-D5 in exhaled breath declines in accordance with
the Farhi equation since the venous blood still has an unaltered isoprene level for 1 to 2
minutes (see minute 22 to 24 in Figure 3). But then, due to the increased inhalation of
deuterated isoprene-D5, the venous blood gains a higher concentration level (compare
with Equation (6)) too and the exhaled concentration of deuterated isoprene-D5 reaches
its former level (see minute 24 to 40). For perspective, considering that both isoprene
compounds can be assumed to have the same blood:gas partition coefficient λb:air, the
profiles in Figure 3 also show that the exercise peak for normal isoprene cannot be
explained by changes in ventilation and perfusion alone.
The dynamic behaviour in Figure 3 has mainly been discussed for illustrative
purposes. In order to validate the 2-compartment model, only the average resting
values of all measured quantities within the last 3 minutes before starting the ergometer
challenge were taken into account (minute 19 to 22). These average values are
summarized in Tables 1 – 3.
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CI,deuterated CI,normal CA,deuterated CA,normal V˙A Q˙c
[ppb] [ppb] [ppb] [ppb] [l/min] [l/min]
Session 1 86.61 11.46 57.06 159.67 6.40 4.53
Session 2 161.88 7.01 131.47 115.12 5.31 4.37
Session 3 202.14 5.16 156.16 100.35 9.56 6.38
Session 4 447.58 8.81 288.41 137.75 8.74 4.66
Session 5 935.78 12.1 390.06 114.79 6.66 4.73
Mean - 8.91±2.93 - 125.54±23.3 7.33±1.76 4.93±0.82
Table 1. Volunteer 1 (male, mass: 68 kg, height: 174 cm): normal and deuterated
inhaled and exhaled isoprene concentrations with corresponding ventilation and
perfusion values.
CI,deuterated CI,normal CA,deuterated CA,normal V˙A Q˙c
[ppb] [ppb] [ppb] [ppb] [l/min] [l/min]
Session 6 49.81 5.48 31.77 45.53 5.75 5.69
Session 7 104.70 6.18 71.62 50.12 5.67 6.11
Session 8 159.72 6.38 106.31 48.73 5.83 5.96
Session 9 226.08 5.74 215.86 48.76 8.95 6.88
Session 10 515.21 7.12 213.93 36.85 8.28 7.48
Mean - 6.18±0.63 - 46.0±5.38 6.9±1.59 6.42±0.74
Table 2. Volunteer 2 (female, mass: 62 kg, height: 168 cm): normal and
deuterated inhaled and exhaled isoprene concentrations with corresponding ventilation
and perfusion values.
CI,deuterated CI,normal CA,deuterated CA,normal V˙A Q˙c
[ppb] [ppb] [ppb] [ppb] [l/min] [l/min]
Session 11 32.09 7.29 22.42 184.59 8.04 4.46
Session 12 68.08 6.07 44.91 180.69 8.06 4.79
Session 13 127.22 6.37 87.93 190.25 8.65 4.54
Session 14 164.33 5.90 137.19 142.16 7.28 4.40
Session 15 617.11 7.81 351.69 170.88 8.13 4.09
Mean - 6.69±0.83 - 173.71±19.0 8.03±0.49 4.46±0.25
Table 3. Volunteer 3 (male, mass: 90 kg, height: 180 cm): normal and deuterated
inhaled and exhaled isoprene concentrations with corresponding ventilation and
perfusion values.
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Volunteer 1 Volunteer 2 Volunteer 3
kmet 16.87± 4.8 7.95± 4.0 22.63± 4.8
Table 4. Metabolic rates (in [l/min]) for deuterated isoprene-D5 for each volunteer.
Q˙c V˙A a CA(0) kprod
[l/min] [l/min] ppb [nmol/min]
Volunteer 1 4.93 7.33 0.669 120.6 216.4
Volunteer 2 6.42 6.9 0.671 41.9 35.7
Volunteer 3 4.46 8.03 0.694 169.0 439.9
Table 5. Production rates for isoprene for each volunteer (with Vmol = 27 l).
From Tables 1 – 3 we are able calculate the metabolic rates for deuterated isoprene-
D5 for each volunteer. To this end, we perform a nonlinear least square optimization
using Equation (8)
∑(CA(CI)
CI
− (r +
V˙A
kmet
)
r + V˙A
kmet
+ λb:air
)2
−→ min (20)
The sum is taken over the respective sessions for each volunteer here, thereby yielding
individual values for kmet. The results are listed in Table 4. Since normal isoprene
and deuterated isoprene-D5 behave similarly from a chemical standpoint, we assume,
neglecting isotopic effects, as a first approximation that both have the same metabolic
rate.
Using the average resting ventilation V˙A, the average resting perfusion Q˙c, and the
metabolic rates in Table 4, we may thus compute the gradient a by Equation (15), and
the corrected average exhaled normal isoprene concentration CA(0) = CA(CI) − aCI.
By employing Equation (18) we can then calculate the corresponding endogenous
production rate for normal isoprene. The results are listed in Table 5.
As an additional remark, one can also calculate the total production rate kprod
and the total metabolic rate kmet from the three compartment model presented in[7] by
combining the two body compartments (richly perfused and peripheral compartment)
kprod = k
rpt
pr + k
per
pr , kmet =
krptmetλb:rptCrpt + k
per
metλb:perCper
Cv¯
.
Here krptpr , k
per
pr denote the production rates in the richly perfused and peripheral
compartment, λb:rpt, λb:per the corresponding partition coefficients, and Crpt, Cper the
corresponding concentrations.
Taking the nominal values from Table 2 and Table C1 in [7] yields kmet = 10 l/min
and kprod = 125.3 nmol/min, which is similar to the values extracted above.
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5. Discussion
In this paper we developed the conceptually simplest compartment model for systemic
VOCs that can be described by the Farhi equation in terms of their exhalation kinetics.
In particular, a special focus is given to the case when the inhaled (e.g., ambient air)
concentration is significantly different from zero. The model elucidates a novel approach
for computing metabolic/production rates of systemic VOCs with low blood:air partition
coefficients from the respective breath concentrations. Moreover, it clarifies how breath
concentration of such VOCS should be corrected when the inhaled concentration cannot
be neglected. The model predictions with respect to an affine relationship between
exhaled breath concentrations and inhaled concentrations are in excellent agreement
with measurements by Spanel et al. [26].
Nevertheless, a number of limitations should be mentioned here. Firstly, in order
to apply this model for the estimation of metabolic/production rates, further studies
with a representative number of patients will be necessary. In particular, the individual
and population ranges of these quantities will have to be determined. In addition, it
should be investigated how these parameters vary with age, body mass, sex, etc.. To
circumvent the intricate measurements of ventilation and perfusion, one could use heart
frequency and breath frequency.
In order to account for long-term exposure, the model should be extended to
incorporate a storage compartment which fills up and depletes according to its partition
coefficient. This yields then a 3-compartment model. For instance, Pleil et al.
demonstrated in [21] that a 3-compartment model suffices to model the long-term
elimination (over 35 hours) of trichloroethylene after exposure. However, for short-
term exposure experiments as carried out in Section 3, the influence of such a storage
compartment will merely be reflected by a slightly different metabolic rate.
When there is an influence of the upper airway walls (i.e., for highly hydrophilic
VOCs), the exhaled concentration deviates considerably from the alveolar concentration,
i.e., Cexhaled 6= CA. In that case the lung must be modeled by at least two compartments
[12] or more [2]. In addition breath concentrations will become flow and temperature
dependent. Due to this fact, for hydrophilic VOCs one also would have to resort to
alternative sampling approaches such as isothermal rebreathing to extract the underlying
alveolar concentration [13]. Also, the formulas for metabolic rates and endogenous
production rates will be different.
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Appendix A. List of symbols
Parameter Symbol
cardiac output Q˙c
averaged mixed venous concentration Cv¯
arterial concentration Ca
ventilation V˙A
inhaled air concentration CI
alveolar air concentration CA
lung volume V˜A
blood:air partition coefficient λb:air
ventilation-perfusion ratio r
exhaled concentration Cexhaled
metabolic rate kmet
production rate kprod
effective volume of the body V˜B
body concentration CB
blood:body partition coefficient λb:B
inhaled air concentration of normal isoprene CI,normal
inhaled air concentration of isoprene-D5 CI,deuterated
alveolar air concentration of isoprene-D5 CA,deuterated
alveolar air concentration of normal isoprene CA,normal
production rate in the richly perfused compartment krptpr
production rate in the peripheral compartment kperpr
blood:richly perfused compartment partition coefficient λb:rpt
blood:peripheral compartment partition coefficient λb:per
richly perfused compartment concentration Crpt
peripheral compartment concentration Cper
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